Daniel Janse
Director/Miembro de la Junta en Triumvira Immunologics USA, Inc. .
Cargos activos de Daniel Janse
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Triumvira Immunologics USA, Inc.
Triumvira Immunologics USA, Inc. Miscellaneous Commercial ServicesCommercial Services Triumvira Immunologics USA, Inc. develops and manufactures novel T cell therapies for cancer. The company is based in Austin, TX and has subsidiaries in Canada. Paul Lammers has been the CEO of the company since 2018. | Director/Miembro de la Junta | - | - |
EnPlusOne Biosciences, Inc
EnPlusOne Biosciences, Inc Packaged SoftwareTechnology Services EnPlusOne Biosciences, Inc is a company that develops an enzymatic synthesis platform to unlock site-specific and diverse RNA modification. The company is based in Watertown, MA. The company was founded by Dan Ahlstedt, George Church, Howon Lee, Daniel Wiegand, Jonathan Rittichier. Daniel Wiegand has been the CEO since incorporation. | Director/Miembro de la Junta | - | - |
Isolere Bio, Inc.
Isolere Bio, Inc. Pharmaceuticals: MajorHealth Technology Part of Donaldson Co., Inc., Isolere Bio, Inc. is an early-stage biotechnology company that develops novel and proprietary reagents. The company is based in Durham, NC. The company was founded in 2017 by Kelli Luginbuhl, Joseph McMahon, Ashutosh Chilkoti. Kelli Luginbuhl has been the CEO since 2017. Isolere Bio was acquired by Donaldson Co., Inc. on February 21, 2023 for $62.50 million. | Director/Miembro de la Junta | - | - |
Historial de carrera de Daniel Janse
Estadísticas
Internacional
Estados Unidos | 4 |
Operativa
Director/Board Member | 3 |
Sectorial
Health Technology | 2 |
Commercial Services | 2 |
Technology Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 3 |
---|---|
Isolere Bio, Inc.
Isolere Bio, Inc. Pharmaceuticals: MajorHealth Technology Part of Donaldson Co., Inc., Isolere Bio, Inc. is an early-stage biotechnology company that develops novel and proprietary reagents. The company is based in Durham, NC. The company was founded in 2017 by Kelli Luginbuhl, Joseph McMahon, Ashutosh Chilkoti. Kelli Luginbuhl has been the CEO since 2017. Isolere Bio was acquired by Donaldson Co., Inc. on February 21, 2023 for $62.50 million. | Health Technology |
Triumvira Immunologics USA, Inc.
Triumvira Immunologics USA, Inc. Miscellaneous Commercial ServicesCommercial Services Triumvira Immunologics USA, Inc. develops and manufactures novel T cell therapies for cancer. The company is based in Austin, TX and has subsidiaries in Canada. Paul Lammers has been the CEO of the company since 2018. | Commercial Services |
EnPlusOne Biosciences, Inc
EnPlusOne Biosciences, Inc Packaged SoftwareTechnology Services EnPlusOne Biosciences, Inc is a company that develops an enzymatic synthesis platform to unlock site-specific and diverse RNA modification. The company is based in Watertown, MA. The company was founded by Dan Ahlstedt, George Church, Howon Lee, Daniel Wiegand, Jonathan Rittichier. Daniel Wiegand has been the CEO since incorporation. | Technology Services |
- Bolsa de valores
- Insiders
- Daniel Janse
- Experiencia